{"disease":{"id":"hyperoxalemia","name":"hyperoxalemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06225544","title":"Lumasiran in Hyperoxalaemic Patients on Haemodialysis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Charite University, Berlin, Germany","has_results":false},{"nct_id":"NCT04119765","title":"Plasma Oxalate in Patient With Short Bowel","phase":"","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT03391804","title":"Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Allena Pharmaceuticals","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}